Securing Foundational Data for Citizen Protection
Focus on Pharmaceuticals Used Over Extended Periods

Photo by Daejeon City Provided

Photo by Daejeon City Provided

View original image

The Daejeon Institute of Health and Environment will conduct quality inspections on hair loss treatment pharmaceuticals that are closely related to citizens' daily lives.


In response to the growing number of patients with hair loss, the institute will launch a quality status survey of domestically distributed hair loss treatment pharmaceuticals starting in March, aiming to support the safe use of these medicines, which are often used over extended periods.


Recently, the number of hair loss patients in South Korea has continued to increase, and the use of hair loss treatment pharmaceuticals has expanded, particularly among younger people in their 20s and 30s. As a result, the importance of quality control for these pharmaceuticals has become even greater.


Accordingly, the institute plans to conduct quality inspections on hair loss treatment pharmaceuticals that are closely associated with daily life, in order to secure foundational data to strengthen drug safety management.


The survey will cover 46 types of hair loss treatment pharmaceuticals that are currently approved and distributed in South Korea. This includes oral prescription drugs containing finasteride and dutasteride, as well as over-the-counter topical drugs containing minoxidil.


For this survey, the Food and Drug Safety Division of Daejeon City will collect distributed products, and the institute will conduct tests on the collected samples. The tests will focus on determining the content of the main ingredients, as well as conducting disintegration and dissolution tests in accordance with the quality standards for each product type.


If any products are found to fail the quality standards, the results will be promptly reported to the relevant regional drug safety authority, and necessary administrative actions, such as recall and disposal orders, will be taken.



Tae-Young Jeong, Director of the Daejeon Institute of Health and Environment, stated, "Hair loss treatment pharmaceuticals are often used for extended periods, so a systematic quality survey at the public institution level is necessary to ensure that citizens can use them with greater peace of mind. Based on the data secured through this survey, we will further strengthen drug safety management and administrative response."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing